Shanghai Kehua Bio-Engineering Co Ltd (002022) - Total Assets
Based on the latest financial reports, Shanghai Kehua Bio-Engineering Co Ltd (002022) holds total assets worth CN¥4.55 Billion CNY (≈ $665.33 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Shanghai Kehua Bio-Engineering Co Ltd working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Shanghai Kehua Bio-Engineering Co Ltd - Total Assets Trend (2001–2025)
This chart illustrates how Shanghai Kehua Bio-Engineering Co Ltd's total assets have evolved over time, based on quarterly financial data.
Shanghai Kehua Bio-Engineering Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Shanghai Kehua Bio-Engineering Co Ltd's total assets of CN¥4.55 Billion consist of 51.9% current assets and 48.1% non-current assets. Also see Shanghai Kehua Bio-Engineering Co Ltd (002022) market capitalisation for the company's overall valuation and market capitalisation.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 18.5% |
| Accounts Receivable | CN¥596.74 Million | 12.9% |
| Inventory | CN¥643.51 Million | 13.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥507.33 Million | 10.9% |
| Goodwill | CN¥608.90 Million | 13.1% |
Asset Composition Trend (2001–2025)
This chart illustrates how Shanghai Kehua Bio-Engineering Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Shanghai Kehua Bio-Engineering Co Ltd share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Kehua Bio-Engineering Co Ltd's current assets represent 51.9% of total assets in 2025, a decrease from 68.6% in 2001.
- Cash Position: Cash and equivalents constituted 18.5% of total assets in 2025, down from 22.1% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 0.0% in 2001.
- Asset Diversification: The largest asset category is inventory at 13.9% of total assets.
Shanghai Kehua Bio-Engineering Co Ltd Competitors by Total Assets
Key competitors of Shanghai Kehua Bio-Engineering Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SIEMENS HEALTH ADR/050
F:SHL1
|
Germany | €44.27 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
|
Somnomed Ltd
AU:SOM
|
Australia | AU$79.90 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
|
Promimic AB
ST:PRO
|
Sweden | Skr75.71 Million |
Shanghai Kehua Bio-Engineering Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.77 | 3.39 | 5.04 |
| Quick Ratio | 1.29 | 2.33 | 3.93 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.02 Billion | CN¥1.96 Billion | CN¥3.22 Billion |
Shanghai Kehua Bio-Engineering Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shanghai Kehua Bio-Engineering Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.19 |
| Latest Market Cap to Assets Ratio | 0.09 |
| Asset Growth Rate (YoY) | -11.4% |
| Total Assets | CN¥4.64 Billion |
| Market Capitalization | $407.94 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Kehua Bio-Engineering Co Ltd's assets below their book value (0.09x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Shanghai Kehua Bio-Engineering Co Ltd's assets decreased by 11.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Shanghai Kehua Bio-Engineering Co Ltd (2001–2025)
The table below shows the annual total assets of Shanghai Kehua Bio-Engineering Co Ltd from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.64 Billion ≈ $679.19 Million |
-11.36% |
| 2024-12-31 | CN¥5.24 Billion ≈ $766.21 Million |
-23.09% |
| 2023-12-31 | CN¥6.81 Billion ≈ $996.19 Million |
-22.75% |
| 2022-12-31 | CN¥8.81 Billion ≈ $1.29 Billion |
+26.71% |
| 2021-12-31 | CN¥6.96 Billion ≈ $1.02 Billion |
+16.36% |
| 2020-12-31 | CN¥5.98 Billion ≈ $874.65 Million |
+61.33% |
| 2019-12-31 | CN¥3.70 Billion ≈ $542.13 Million |
+5.74% |
| 2018-12-31 | CN¥3.50 Billion ≈ $512.71 Million |
+29.02% |
| 2017-12-31 | CN¥2.72 Billion ≈ $397.38 Million |
+16.89% |
| 2016-12-31 | CN¥2.32 Billion ≈ $339.96 Million |
+12.15% |
| 2015-12-31 | CN¥2.07 Billion ≈ $303.14 Million |
+44.96% |
| 2014-12-31 | CN¥1.43 Billion ≈ $209.12 Million |
+4.30% |
| 2013-12-31 | CN¥1.37 Billion ≈ $200.50 Million |
+6.59% |
| 2012-12-31 | CN¥1.29 Billion ≈ $188.10 Million |
+6.97% |
| 2011-12-31 | CN¥1.20 Billion ≈ $175.85 Million |
+10.57% |
| 2010-12-31 | CN¥1.09 Billion ≈ $159.05 Million |
+17.40% |
| 2009-12-31 | CN¥925.84 Million ≈ $135.48 Million |
+25.57% |
| 2008-12-31 | CN¥737.31 Million ≈ $107.89 Million |
+20.35% |
| 2007-12-31 | CN¥612.64 Million ≈ $89.65 Million |
+26.45% |
| 2006-12-31 | CN¥484.49 Million ≈ $70.90 Million |
+6.01% |
| 2005-12-31 | CN¥457.03 Million ≈ $66.88 Million |
+2.63% |
| 2004-12-31 | CN¥445.33 Million ≈ $65.17 Million |
+84.61% |
| 2003-12-31 | CN¥241.23 Million ≈ $35.30 Million |
+6.98% |
| 2002-12-31 | CN¥225.50 Million ≈ $33.00 Million |
+35.18% |
| 2001-12-31 | CN¥166.81 Million ≈ $24.41 Million |
-- |
About Shanghai Kehua Bio-Engineering Co Ltd
Shanghai Kehua Bio-Engineering Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sale of in vitro diagnostic reagents and medical testing equipment and services in China and internationally. The company offers immunoassay and clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management solution, and automated co… Read more